HomeSNDX • NASDAQ
add
Syndax Pharmaceuticals Inc
Previous close
$15.60
Day range
$15.41 - $16.26
Year range
$15.03 - $25.34
Market cap
1.37B USD
Avg Volume
1.74M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 12.50M | — |
Operating expense | 36.99M | 75.14% |
Net income | -84.13M | -64.48% |
Net profit margin | -673.01 | — |
Earnings per share | -0.98 | -34.25% |
EBITDA | -89.58M | -58.96% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 406.40M | 8.71% |
Total assets | 425.81M | 6.66% |
Total liabilities | 59.38M | 48.31% |
Total equity | 366.43M | — |
Shares outstanding | 85.36M | — |
Price to book | 3.64 | — |
Return on assets | -49.61% | — |
Return on capital | -55.79% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -84.13M | -64.48% |
Cash from operations | -62.32M | -39.57% |
Cash from investing | 86.85M | 116.70% |
Cash from financing | 3.10M | 67.37% |
Net change in cash | 27.62M | 1,113.69% |
Free cash flow | -21.64M | 1.94% |
About
Founded
2005
Headquarters
Website
Employees
112
